Table 3.
Characteristic | Overall N (%) | No HPV (n, %) | Incident HPV (n, %) | P-valuea |
---|---|---|---|---|
Recall period: past 6 months | ||||
Mean days since last interview | 227.3 (±60) | 227.2 (±60) | 227.6 (±69) | 0.94 |
Smoked any cigarettes | 202 (23) | 172 (23) | 30 (23) | 0.84 |
Drank any alcoholic beverages | 753 (85) | 634 (84) | 119 (88) | 0.27 |
Injected any recreational drugs | 19 (2) | 14 (2) | 5 (4) | 0.39 |
Used rectal drugs | 43 (5) | 30 (4) | 13 (10) | 0.03 |
Number of male partners with whom the participant was the receptive partner | 0.03 | |||
0–1 | 566 (64) | 491 (65) | 75 (55) | |
2–7 | 227 (26) | 190 (25) | 37 (27) | |
8+ | 95 (11) | 71 (9) | 24 (18) | |
Number of ‘new’ male partners with whom the participant was the receptive partner | 2.9 (±9) | 2.4 (±8) | 5.3 (±14) | 0.01 |
Frequency of receptive intercourse (participant was the receptive partner) | 0.03 | |||
No receptive intercourse | 379 (43) | 327 (44) | 52 (38) | |
1–3 times/month | 399 (45) | 342 (46) | 57 (42) | |
1+ times/week | 110 (12) | 83 (11) | 27 (20) | |
Number of male partners with whom the participant was the insertive partner | 0.09 | |||
0–1 | 589 (66) | 509 (68) | 80 (59) | |
2–7 | 210 (24) | 175 (23) | 35 (26) | |
8+ | 89 (10) | 68 (9) | 21 (15) | |
Number of new male partners with whom the participant was the insertive partner | 2.6 (±7) | 2.4 (±7) | 3.4 (±8) | 0.18 |
Number oral–anal contact partners (participant received anal contact) | 0.04 | |||
0–1 | 678 (76) | 578 (77) | 100 (74) | |
2–7 | 169 (19) | 148 (20) | 21 (16) | |
8+ | 41 (5) | 26 (4) | 15 (11) | |
Number new male oral–anal contact partners (participant received anal contact) | 1.7 (±5) | 1.5 (±4) | 2.9 (±8) | 0.04 |
Objects in anus | 243 (27) | 197 (26) | 46 (34) | 0.08 |
Frequency of object use | 0.02 | |||
0 times | 645 (73) | 555 (74) | 90 (66) | |
1 – 6 times | 150 (17) | 129 (17) | 21 (15) | |
7 + times | 93 (11) | 68 (9) | 25 (18) | |
Recall period: past 30 days | ||||
Number male partners | 0.07 | |||
0 | 194 (22) | 164 (22) | 30 (22) | |
1 | 303 (34) | 267 (35) | 36 (26) | |
2+ | 391 (44) | 321 (43) | 70 (52) | |
Number of male partners with whom the participant was the receptive partner | 0.9 (±2) | 0.8 (±2) | 1.2 (±2) | 0.07 |
Frequency of receptive intercourse (participant was the receptive partner) | 3.1 (±4) | 2.9 (±4) | 4.5 (±5) | 0.005 |
Number of male partners with whom the participant was the insertive partner | 0.9 (±2) | 0.9 (±2) | 0.9 (±2) | 0.92 |
Frequency of insertive intercourse (participant was the insertive partner) | 3.3 (±6) | 3.2 (±5) | 4.1 (±8) | 0.39 |
Objects in anus | 164 (68) | 133 (68) | 31 (67) | 0.99 |
Frequency of objects used | 3.3 (±4) | 3.3 (±4) | 3.5 (±2) | 0.66 |
HIV disease status variables | ||||
Mean CD4+ cell count (current visit) | 509.5 (±288) | 513.2 (±290) | 489.1 (±278) | 0.36 |
<200 | 98 (11) | 78 (11) | 20 (15) | |
200–500 | 382 (44) | 329 (44) | 53 (40) | |
>500 | 394 (45) | 334 (45) | 60 (45) | |
Mean CD4+ cell count (previous visit) | 495.2 (±280) | 494.2 (±280) | 500.7 (±281) | 0.81 |
HIV viral load (current visit) | 0.85 | |||
<500 | 583 (67) | 499 (67) | 84 (64) | |
500–4000 | 83 (10) | 71 (10) | 12 (9) | |
4001 –20 000 | 112 (12) | 93 (12) | 19 (15) | |
>20 000 | 95 (11) | 79 (11) | 16 (12) |
HPV, human papillomavirus.
P-value from generalized estimating equations (GEE) accounting for correlation from taking repeated measures of participants.